PET and SPECT Preclinical Imaging Systems
Solicitation number LL 03-26-1123
Publication date
Closing date and time 2026/07/23 14:00 EDT
Description
McMaster University invites qualified bidders to submit responses for the supply of PET and SPECT preclinical imaging systems that can perform quantitative imaging and dosimetry for therapeutic isotopes (e.g., Lu-177, Tb-161) on live animals (rats, mice) in accordance with the terms of this Request for Proposals.
Bidders must quote the entire bid. Partial bids will not be accepted.
The proposed PET and SPECT preclinical imaging systems are essential components of our radiopharmaceutical and theranostics research program within the newly established McMaster Institute for Radiopharmaceutical Imaging and Therapy (MIRIT). These instruments will enable in vivo validation of novel tracers and therapeutics developed at McMaster, supporting the full pipeline from isotope production and radiochemistry through to biological evaluation and clinical translation.
In addition to conventional diagnostic imaging, we will also use these systems to study therapeutic radioisotopes such as lutetium-177 and terbium-161. These isotopes provide intrinsic imaging capability, allowing us to perform quantitative imaging and dosimetry without the need for separate companion PET tracers, which is highly valuable for theranostics development.
The systems will be used to:
* Evaluate biodistribution, pharmacokinetics, and target engagement of new radiopharmaceuticals
* Track disease progression and therapeutic response in animal models
* Perform quantitative imaging and dosimetry for therapeutic isotopes (e.g. Lu-177, Tb-161)
* Generate data required for regulatory submissions and early-phase clinical translation
* Support multidisciplinary projects across oncology, neurology, cardiology, and inflammation
This is a one-time purchase of PET and SPECT preclinical imaging systems including 1-year warranty. Additional warranty and service period of up to 3 years with the option to renew on a yearly basis as required, at McMaster’s sole discretion.
Bidders must quote the entire bid. Partial bids will not be accepted.
The proposed PET and SPECT preclinical imaging systems are essential components of our radiopharmaceutical and theranostics research program within the newly established McMaster Institute for Radiopharmaceutical Imaging and Therapy (MIRIT). These instruments will enable in vivo validation of novel tracers and therapeutics developed at McMaster, supporting the full pipeline from isotope production and radiochemistry through to biological evaluation and clinical translation.
In addition to conventional diagnostic imaging, we will also use these systems to study therapeutic radioisotopes such as lutetium-177 and terbium-161. These isotopes provide intrinsic imaging capability, allowing us to perform quantitative imaging and dosimetry without the need for separate companion PET tracers, which is highly valuable for theranostics development.
The systems will be used to:
* Evaluate biodistribution, pharmacokinetics, and target engagement of new radiopharmaceuticals
* Track disease progression and therapeutic response in animal models
* Perform quantitative imaging and dosimetry for therapeutic isotopes (e.g. Lu-177, Tb-161)
* Generate data required for regulatory submissions and early-phase clinical translation
* Support multidisciplinary projects across oncology, neurology, cardiology, and inflammation
This is a one-time purchase of PET and SPECT preclinical imaging systems including 1-year warranty. Additional warranty and service period of up to 3 years with the option to renew on a yearly basis as required, at McMaster’s sole discretion.
Bidding and Documents are available on http://www.merx.com. Fees may apply; See https://www.merx.com/public/pricing for more information.
Contract duration
The estimated contract period will be 0 month(s), with a proposed start date of 2026/07/31.
Trade agreements
-
Canadian Free Trade Agreement (CFTA)
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
-
Please refer to tender description or tender documents
Contact information
Contracting organization
- Organization
-
McMaster University
- Address
-
1280 Main Street WestHamilton, Ontario, L8S 4L8Canada
- Contracting authority
- Linda Leo
- Phone
- 905-525-9140 x24678
- Email
- leolin@mcmaster.ca
Bidding details
Full details for this tender opportunity are available on a third-party site
Click on the button below to be directed to this website. Note that on the third-party site you may need an account to view and/or bid on this tender. Information on any fees or additional costs to access the full details is outlined in the Description tab of this tender opportunity.